Friday, July 03, 2015 12:16:44 PM
new data on LymPro multivarant S/S numbers could indeed "Change the Math" and bring about a cataclysmic change much need by everyone.
The closing of ESS would be a huge shot in the arm as well.
However, cash upfront and/or shareholder friendly financing would be the quintessentail "thunder and lightening" that we all need so desperately.
This daily drip style dilution is killing us all slowly.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
